Seattle Genetics (SGEN) is traded on NASDAQ in USA. It is located in WASHINGTON, U.S.A and employs 1,100 people. Seattle Genetics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap
' category with current market capitalization of 7.94 B. Seattle Genetics conducts business under Healthcare
sector and is part of Biotechnology
industry. This company has 157.95 M outstanding shares of which 12.74 M shares are at this time shorted by private and institutional investors with about 13.38 trading days to cover.
SEATTLE GENETICS currently holds about 413.17 M in cash with (118.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.62.
Check Seattle Genetics Probability Of Bankruptcy